EU4Monitoring Drugs: European Neighbourhood Policy countries attended prevalence and patterns of drug use expert meeting 2020

May 25, 2020
Share on

The 2020 annual expert meeting on the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) epidemiological indicator ‘Prevalence and patterns of drug use among the general population’ (often referred to as the ‘General population surveys indicator’) took place on-line on 19 and 20 May.

The meeting brought together experts from almost all EU Member States and Norway, Instrument for Pre-Accession Assistance (IPA) and European Neighbourhood Policy (ENP) countries, Russian Federation and Switzerland.

These regular meetings on the indicator change their focus from year to year. This year, due to the restrictions posed by COVID-19, it was decided to have a shorter online meeting, focusing on methodological developments on the indicator, how hair analysis can complement survey data, the implementation of Random Response Technique to assess underreporting in drug use surveys and the challenges of implementing a general population survey on drugs during a pandemic.

The second day was dedicated to the kick-off session of the European Web Survey on Drugs 2021.

EMCDDA has launched the three-year EU-funded project EU4Monitoring Drugs in January 2019. The project supports national and regional readiness in the ENP area to identify and respond to drug-related health and security threats.


Read more

Press release

EU4Monitoring Drugs webpage

Countries covered:

  • Algeria
  • Israel
  • Jordan
  • Lebanon
  • Libya
  • Morocco
  • Palestine *
  • Tunisia